Evidence map›Paper›PMID 35884184›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Investigating Dual-Species

Dolunay Gülmez, Jason L Brown, Mark C Butcher, Christopher Delaney, Ryan Kean, Gordon Ramage, Bryn Short

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. The rising challenge ofFrontiers in microbiology · 2025
    Review
  3. Article
  4. Journal of clinical medicine · 2024
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Dolunay GülmezMedical Microbiology Department, Faculty of Medicine, Hacettepe University, Ankara 06100, Turkey.ORCID 0000-0001-9021-0439
Jason L BrownSchool of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, Glasgow Dental Hospital, Glasgow University, Glasgow G2 3JZ, UK.ORCID 0000-0002-8168-5333
Mark C ButcherSchool of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, Glasgow Dental Hospital, Glasgow University, Glasgow G2 3JZ, UK.
Christopher DelaneySchool of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, Glasgow Dental Hospital, Glasgow University, Glasgow G2 3JZ, UK.
Ryan KeanDepartment of Biological and Biomedical Sciences, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow G2 3JZ, UK.
Gordon RamageSchool of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, Glasgow Dental Hospital, Glasgow University, Glasgow G2 3JZ, UK.ORCID 0000-0002-0932-3514
Bryn ShortSchool of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, Glasgow Dental Hospital, Glasgow University, Glasgow G2 3JZ, UK.
University of Glasgow · GBGlasgow Caledonian University · GBHacettepe University · TR

Funding

GlaxoSmithKline (UK) BB/V509541/1Hacettepe University Scientific Research Projects Coordination Unit TUI-2019-18176
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antisepticbiofilmCandida aurispolymicrobialStaphylococcus spp.

Identifiers

PMID35884184
PMCPMC9312070
OpenAlexW4285043481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.